NCT07043127 Impact of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Elective Hip Replacement
| NCT ID | NCT07043127 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bonn |
| Condition | Total Hip Arthroplasty (THA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-01-01 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the present project, the framework conditions of outpatient rehabilitation at the Bonn Center for Outpatient Rehabilitation will now be used to prove whether sports science-controlled strength and BFR training has a similar effect in the postoperative rehabilitation phase. Strength and BFR training in medical training therapy complements daily exercise therapy in order to ensure implementation in the guideline-based rehabilitation process. . The interventions are carried out as part of the exercise therapy units in outpatient rehabilitation ETM01 following the RTS hip and knee TEP basis KTL 2020.
Eligibility Criteria
Inclusion Criteria: * Ability for Rehabilitation * Total Hip Arthroplasty Surgery during the last 4 Weeks Exclusion Criteria: * Sickle Cell Anemia * Iatrogenic changes in the vessels of the lower Extremity (e.g. Stents) * Open Wounds or Infections of the lower Extremity
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07043127 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Total Hip Arthroplasty (THA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07043127 currently recruiting?
Yes, NCT07043127 is actively recruiting participants. Contact the research team at alexander.franz@ukbonn.de for enrollment information.
Where is the NCT07043127 trial being conducted?
This trial is being conducted at Bonn, Germany.
Who is sponsoring the NCT07043127 clinical trial?
NCT07043127 is sponsored by University Hospital, Bonn. The trial plans to enroll 30 participants.